dimecres, 16 de juliol del 2014

Could Medtronic-Covidien deal get caught in anti-inversion legislation?




Lawmakers aim to prohibit companies from shifting their headquarters overseas in order to evade U.S. taxes, a measure that would apply retroactively to deals such as Medtronic's $43 billion acquisition of Covidien.





Could Medtronic-Covidien deal get caught in anti-inversion legislation?



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oIDGEa

Cap comentari:

Publica un comentari a l'entrada